Specialty Research and Innovation
-
Medical Grand Rounds: Pathogenesis and Management of Respiratory Failure in COVID-19: What We Know So Far
On March 26, 2020, the Department of Medicine held its third virtual Grand Rounds presentation related to COVID-19. Benjamin Medoff, MD, chief of Pulmonary and Critical Care at Massachusetts General Hospital, along with other members of the Greater Boston medical community, presented on respiratory failure in COVID-19, including management, treatment in clinical trials and the need for biomarkers.
-
Using Chloroquine to Treat COVID-19: Q&A with Raghu Chivukula, MD, PhD
Raghu Chivukula, MD, PhD, a physician-scientist in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, explains what is currently known about chloroquine and its use to treat COVID-19 patients.
-
Developing New Assays for Novel COVID-19: Q&A with David Louis, MD
David Louis, MD, pathologist-in-chief at Massachusetts General Hospital, explains how COVID-19 assays are being rapidly developed and what Mass General is doing to alleviate the scarcity of tests.
-
Hypertension and CVD Are Among Risk Factors for Severe COVID-19
Many patients in a cardiology practice are at risk of developing severe COVID-19 if they become infected with SARS-CoV-2, the new coronavirus.
-
Cardiology Care During the COVID-19 Pandemic: Guidance for Treating Both Uninfected and Infected Patients
Routine use of ACE inhibitors and angiotensin II receptor blockers should be continued, but these drugs should not be started for patients who develop COVID-19.
-
Mass General First in New England to Enroll Patients in Remdesivir Clinical Trial for COVID-19
The hospital announces that the Infectious Disease Division has started enrolling patients in an international study of the antiviral drug, Remdesivir, which aims to treat those with the novel coronavirus (COVID-19).